- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in glenmark
Glenmark to divest select Anti-Allergy brands to Dr Reddy's in Russia, Ukraine, Kazakhstan and Uzbekistan in anticipation of its "Ryaltris" Launch
Glenmark to divest select Anti-Allergy brands to Dr Reddy's in Russia, Ukraine, Kazakhstan and Uzbekistan in anticipation of its "Ryaltris" Launch
Read More
Glenmark Pharma Gets USFDA Nod For Generic Drug
The company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF Prism CV's Rapamune tablets
Read MoreGlenmark's consolidated revenue grew by 0.94 per cent at Rs 23,447.87 million for Q1 FY 2020-21
Glenmark's consolidated revenue grew by 0.94 per cent at Rs 23,447.87 million for Q1 FY 2020-21
Read MoreGlenmark introduces higher strength (400 mg) of FabiFlu® to reduce the pill burden of COVID-19 treatment
Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce the pill burden of COVID-19 treatment
Read MoreGlenmark announces top-line results from phase 3 clinical trial of Favipiravir in patients with mild to moderate COVID-19
Glenmark announces top-line results from phase 3 clinical trial of Favipiravir in patients with mild to moderate COVID-19
Read MoreCOVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3 clinical trial
COVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3 clinical trial
Read MoreGlenmark responds to DCGI letter seeking clarification on Fabiflu
Glenmark responds to DCGI letter seeking clarification on Fabiflu
Read More
Glenmark Cuts Price Of COVID-19 Drug Favipiravir Version To $1 Per Tablet
A treatment course with FabiFlu would require a patient to take 122 tablets over 14 days, and will now cost 8,475 rupees ($112.80) per patient at the new price.
Read More
HUL Completes Acquisition Of Female Hygiene Brand Vwash From Glenmark
The shares of HUL were trading at Rs 2,149 apiece on BSE, down 1.15 per cent from their previous close.
Read More
Anti-viral Drug Favipiravir Shows Clinical Improvement In Mild, Moderate COVID-19 Cases: Glenmark
However, it said that pregnant and lactating mothers were not included in the clinical trial.
Read MoreAnti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases
Read More
Glenmark To Conduct Trials In India For Potential COVID-19 Drug
Glenmark will initially enroll 150 patients with mild-to-moderate COVID-19 in a randomized trial that will compare favipiravir with standard supportive care.
Read More
HUL Share Price Jumps 8 Pc After Acquiring Vwash Brand From Glenmark
HUL is India's largest fast-moving consumer goods (FMCG) company with its products touching the lives of nine out of ten households in the country.
Read More
Dr Reddy’s, Sun Pharma, Glenmark Face US price Fixing Charge
The states are seeking to expand the complaint to include Actavis Holdco US, Actavis Pharma, Ascend Laboratories, Apotex Corp, Dr Reddy’s Laboratories (DRL), Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Lannett Company, etc.
Read More
Glenmark Pharma: A Healthy Dose Of Growth
Glenmark, which has graduated to a global organisation in a very short span with its expanded manufacturing footprint, international operations and global employee base, reported a 276.08 per cent rise in revenue since 2012
Read More